Overview

The Gene Technology Act 2000, enacted by the Commonwealth Parliament, aims to regulate the use, handling, and release of genetically modified organisms, including plants, in Australia. This Act was introduced to address the need for a comprehensive framework to manage potential risks associated with genetically modified organisms, ensuring the protection of human health, safety, and the environment. The Gene Technology Regulator, under this Act, is responsible for assessing applications for field trials and issuing licences accordingly. In the context of the proposed field trial of genetically modified chickpeas by Queensland University of Technology, the Regulator has prepared a Risk Assessment and Risk Management Plan (RARMP) to evaluate the potential environmental and health impacts. The Regulator is currently seeking public submissions on this application, inviting stakeholders to comment on issues relating to human health and safety and environmental protection before making a decision on whether to issue the licence. This consultation aims to incorporate public feedback into the decision-making process, reflecting the policy objective of balancing innovation in genetic technology with stringent risk management.

Scope and Application

The scope of the Gene Technology Act 2000 (Cth) is pertinent to the proposed field trial of genetically modified chickpea by the Queensland University of Technology. The Act applies to the entities and individuals involved in the genetically modified organism field trial, including the applicant and the site location within the Tablelands Regional Council in Queensland. The Act also encompasses the conduct and transactions related to the genetically modified chickpea, specifically focusing on its drought and abiotic stress tolerance attributes. The Act extends its jurisdiction across the Commonwealth of Australia, ensuring that all genetically modified activities comply with national standards and regulations. The exclusions and exemptions from the Act are clearly defined, and the application of the Act may be extended or restricted through subordinate instruments such as regulations and codes of practice. The public is invited to comment on the proposed field trial, with submissions on the Risk Assessment and Risk Management Plan referencing DIR 166 to be submitted by 29 April 2019 to the Office of the Gene Technology Regulator.

Key Provisions

The key provision of this legislation (section 1) is the assessment of an application by the Gene Technology Regulator (GTRA) for a field trial of genetically modified (GM) chickpea proposed by Queensland University of Technology. This trial, which aims to test the chickpea’s drought and abiotic stress tolerance, is proposed to take place in the Tablelands Regional Council in Queensland over a total area of 3 hectares per year for up to 6 seasons (section 2). Importantly, the GM chickpea grown in the field trial is not intended for human food or animal feed (section 3). In terms of obligations, the GTRA must prepare a Risk Assessment and Risk Management Plan (RARMP) for this application (section 4). They are also mandated to seek written submissions from interested parties on issues relating to the protection of human health and safety and the environment (section 5). This is a critical step in their decision-making process regarding whether to issue the licence for the field trial. Failure to comply with the requirements of this legislation may result in various consequences. Although the specific offences and penalties are not detailed in the text, it is generally understood that breaches of gene technology legislation can lead to civil and criminal penalties under the Gene Technology Act 2000. These can include fines, imprisonment, or both, depending on the severity and nature of the offence. It is crucial for all parties involved to adhere to the outlined procedures and timelines, such as submitting written submissions by 29 April 2019, as referenced in section 6. This is to ensure compliance with the law and avoid potential legal repercussions.